William Blair Has Pessimistic Outlook of Exagen Q2 Earnings
Exagen Inc. (NASDAQ:XGN – Free Report) – William Blair dropped their Q2 2025 earnings per share estimates for Exagen in a research report issued to clients and investors on Monday, May 5th. William Blair analyst A. Brackmann now anticipates that the company will post earnings of ($0.18) per share for the quarter, down from their […]
